Ask questions and gain insights about this stock now with Rize AI
TDOC logo

Teladoc Health, Inc.

TDOC

Stock Analysis

$8.53

+0.00 (+0.00%)• Live

Teladoc Health, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for Teladoc Health, Inc.

Key Financial Metrics

for Teladoc Health, Inc.

2024 FY
P/E Ratio
-1.28
Revenue Growth
-1.26%
EPS Growth
-331.62%
Market Cap
$1.30B
Dividend Yield
0.00%
Debt/Equity
1.11
ROIC
-10.39%
FCF Yield
+16.09%
View additional metrics

Valuation

P/B Ratio0.91
EV/Sales0.66

Financial Health

Current Ratio1.68
Return on Assets-57.26%

Analyst Recommendations

for Teladoc Health, Inc.

40 analysts
Consensus: Hold

About

for Teladoc Health, Inc.

Company Details

for Teladoc Health, Inc.

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

Charles Divita III, CPA

Employees

4,620

Market Cap

1.51B

Exchange

New York Stock Exchange

IPO Date

June 30, 2015

CIK

0001477449

ISIN

US87918A1051

CUSIP

87918A105

Country

US

Balance Sheet

for Teladoc Health, Inc.

Cash Flow Statement

for Teladoc Health, Inc.

Income Statement

for Teladoc Health, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.